Previous
Arsenal
Queens Park Rangers
2
1
FT
Game Details
Chelsea
West Ham United
2
0
FT
Game Details
Burnley
Liverpool
0
1
FT
Game Details
Everton
Stoke City
0
1
FT
Game Details
Manchester United
Newcastle United
3
1
FT
Game Details
Leicester City
Tottenham Hotspur
1
2
FT
Game Details
West Bromwich Albion
Manchester City
1
3
FT
Game Details
Next

Rewind to Boxing Day 1963

Barclays Premier League
Read

De Bruyne undergoing Chelsea medical

Kevin De Bruyne appears on the verge of signing a deal with Chelsea amid reports the Genk star is undergoing a medical with the Premier League club.

• Genk confirm De Bruyne Chelsea talks

It is claimed De Bruyne, 20, will pen a five-and-a-half year contract at Chelsea after a fee in the region of £7 million was agreed.

The Belgium international is then expected to be loaned back to Genk for the remainder of the season before joining up with the Blues in the summer.

A Genk spokesman is quoted by the Mirror as saying: "Dirk Degraen is in London and the expectation is that it (the transfer of De Bruyne) will be finished this week.

"The assumption is that Kevin de Bruyne will be transferred to Chelsea and then will finish the season (on loan) at Genk."

Attacking midfielder De Bruyne will become the third Belgian to join Chelsea in the last six months, following the arrivals of Romelu Lukaku and Thibaut Courtois last summer.

Andre Villas-Boas had earlier said that De Bruyne signing was down to the club.

"It is a target decided by the club," he said. "'He is a player the club have scouted for some time and I am a manager who respects club policy.

"A club have to look to the future whether it's with this manager or another. He's a good bet for the future. I will do everything in my power for him to reach maximum potential."

Comments

Use a Facebook account to add a comment, subject to Facebook's Terms of Service and Privacy Policy. Your Facebook name, photo & other personal information you make public on Facebook will appear with your comment, and may be used on ESPN's media platforms. Learn more.